Bavarian Nordic A/S
BAVA.CODrugs in Pipeline
29
Phase 3 Programs
10
Upcoming Catalysts
2
Next Catalyst
Nov 30, 2026
29wMarket Overview
Stock performance and key metrics
2 upcoming, 1 past
IMVAMUNE®
Smallpox
FD MVA-BN
Smallpox
CHIKV VLP vaccine booster
Chikungunya Virus Infection
PXVX0200
Cholera
CHIKV VLP vaccine
Chikungunya Virus
PXVX0200 Lot A
Cholera
PROSTVAC-V
Prostate Cancer Metastatic
CHIKV VLP/adjuvant
Chikungunya Virus
MVA BN®
18-42 Year Old Healthy Vaccinia-naïve Subjects
ABNCoV2
COVID-19 Disease
MVA-mBN294B
RSV Infection
MVA-mBN32
HIV Infections
Jynneos
Monkeypox (Mpox)
ABNCoV2 100ug
COVID-19 Disease
CHIKV VLP, adjuvanted
Chikungunya Virus
PROSTVAC®-VF/TRICOM™
Prostate Cancer
LF formulation of IMVAMUNE®
Smallpox
MVA-BN® (IMVAMUNE)
Smallpox
IMVAMUNE
Smallpox
Chikungunya
Chikungunya
MVA-BN
Monkeypox (Mpox)
BN-Brachyury plus radiation
Chordoma
CHIKV VLP/unadjuvanted
Chikungunya Virus Infection
CV301
Bladder Cancer
MVA-BN-WEV
Encephalitis
MVA-mBN85B
Measles
MVA-nef
HIV Infection
MVA-BN-RSV
Respiratory Syncytial Virus Infections
IMVAMUNE (MVA-BN)
Smallpox
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
IMVAMUNE® | Phase 3 | Smallpox | - | - |
FD MVA-BN | Phase 3 | Smallpox | - | - |
CHIKV VLP vaccine booster | Phase 3 | Chikungunya Virus Infection | - | - |
PXVX0200 | Phase 3 | Cholera | - | - |
CHIKV VLP vaccine | Phase 3 | Chikungunya Virus | - | - |
PXVX0200 Lot A | Phase 3 | Cholera | - | - |
PROSTVAC-V | Phase 3 | Prostate Cancer Metastatic | - | - |
CHIKV VLP/adjuvant | Phase 3 | Chikungunya Virus | - | - |
MVA BN® | Phase 3 | 18-42 Year Old Healthy Vaccinia-naïve Subjects | - | - |
ABNCoV2 | Phase 3 | COVID-19 Disease | - | - |
MVA-mBN294B | Phase 2 | RSV Infection | - | - |
MVA-mBN32 | Phase 2 | HIV Infections | - | - |
Jynneos | Phase 2 | Monkeypox (Mpox) | - | - |
ABNCoV2 100ug | Phase 2 | COVID-19 Disease | - | - |
CHIKV VLP, adjuvanted | Phase 2 | Chikungunya Virus | - | - |
PROSTVAC®-VF/TRICOM™ | Phase 2 | Prostate Cancer | - | - |
LF formulation of IMVAMUNE® | Phase 2 | Smallpox | - | - |
MVA-BN® (IMVAMUNE) | Phase 2 | Smallpox | - | - |
IMVAMUNE | Phase 2 | Smallpox | - | - |
Chikungunya | Phase 2 | Chikungunya | - | - |
MVA-BN | Phase 2 | Monkeypox (Mpox) | - | - |
BN-Brachyury plus radiation | Phase 2 | Chordoma | - | - |
CHIKV VLP/unadjuvanted | Phase 2 | Chikungunya Virus Infection | - | - |
CV301 | Phase 2 | Bladder Cancer | - | - |
MVA-BN-WEV | Phase 2 | Encephalitis | - | - |
MVA-mBN85B | Phase 2 | Measles | - | - |
MVA-nef | Phase 2 | HIV Infection | - | - |
MVA-BN-RSV | Phase 2 | Respiratory Syncytial Virus Infections | - | - |
IMVAMUNE (MVA-BN) | Phase 2 | Smallpox | - | - |